Articles producció científicaMedicina i Cirurgia

Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study.

  • Dades identificatives

    Identificador:  imarina:9446268
    Autors:  Amigó N; Castelblanco E; Julve J; Martínez-Micaelo N; Alonso N; Hernández M; Ribalta J; Guardiola M; Torán-Monserrat P; Lopez-Lifante V; Herrero-Alonso C; Arteaga I; Ortega E; Franch-Nadal J; Mauricio D
    Resum:
    Traditional risk factors cannot accurately predict cardiovascular events (CVE) in type 2 diabetes (T2D). The LIPOCAT study aimed to prospectively evaluate the clinical utility of advanced lipoprotein characteristics and glycoproteins to predict future cardiovascular events (CVE) in a large cohort of subjects with type 2 diabetes mellitus (T2D). From four different Spanish prospective cohorts, a total of 933 T2D subjects were selected to form the LIPOCAT study. Advanced 1H-Nuclear Magnetic Resonance (1H-NMR) analysis included lipoprotein (Liposcale®) and glycoprotein (Glycoscale) profiling. Random forest classification models and Area Under the Receiver Operating Characteristics (AUROC) analysis were used to assess the differential contribution of advanced variables in predicting CVE. Validation was performed using an external cohort. Out of 933 T2D subjects, 104 reported a CVE during follow-up. Analysis of Liposcale®/Glycoscale uncovered elevations in the circulating VLDL-cholesterol(C), remnant IDL-triglycerides (TG) and LDL-TG in subjects with CVE, along with glycoproteins (Glyc) A and B. Moreover, the incorporation of advanced Liposcale® variables to a base model constructed with traditional risk factors significantly improved the prediction of CVE, as evidenced by 1.5-fold increase in the C statistic (AUROC), reaching AUROC values of 0.756. In the independent validation cohort, similar improvements in AUROC values were observed by adding the advanced variables to the traditional models. Advanced 1H-NMR analysis revealed previously hidden lipoprotein and glycoprotein characteristics associated with CVE in T2D subjects.
  • Altres:

    Enllaç font original: https://cardiab.biomedcentral.com/articles/10.1186/s12933-025-02636-5
    Referència de l'ítem segons les normes APA: Amigó N; Castelblanco E; Julve J; Martínez-Micaelo N; Alonso N; Hernández M; Ribalta J; Guardiola M; Torán-Monserrat P; Lopez-Lifante V; Herrero-Alons (2025). Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study.. Cardiovascular Diabetology, 24(1), 88-. DOI: 10.1186/s12933-025-02636-5
    Referència a l'article segons font original: Cardiovascular Diabetology. 24 (1): 88-
    DOI de l'article: 10.1186/s12933-025-02636-5
    Any de publicació de la revista: 2025
    Entitat: Universitat Rovira i Virgili
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    Data d'alta del registre: 2025-03-22
    Autor/s de la URV: Guardiola Guionnet, Montserrat / Ribalta Vives, Josep
    Departament: Medicina i Cirurgia
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Tipus de publicació: Journal Publications
    Autor segons l'article: Amigó N; Castelblanco E; Julve J; Martínez-Micaelo N; Alonso N; Hernández M; Ribalta J; Guardiola M; Torán-Monserrat P; Lopez-Lifante V; Herrero-Alonso C; Arteaga I; Ortega E; Franch-Nadal J; Mauricio D
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Àrees temàtiques: Saúde coletiva, Medicina ii, Medicina i, Internal medicine, Interdisciplinar, Farmacia, Endocrinology, diabetes and metabolism, Endocrinology & metabolism, Educação física, Ciências biológicas ii, Ciências biológicas i, Cardiology and cardiovascular medicine, Cardiac & cardiovascular systems, Biotecnología
    Adreça de correu electrònic de l'autor: montse.guardiola@urv.cat, josep.ribalta@urv.cat
  • Paraules clau:

    Type 2 diabetes
    Time factors
    Spain
    Risk factors
    Risk assessment
    Reproducibility of results
    Proton magnetic resonance spectroscopy
    Prospective studies
    Prognosis
    Predictive value of tests
    Nuclear magnetic resonance spectroscopy
    Middle aged
    Male
    Lipoproteins
    Humans
    Heart disease risk factors
    Glycoproteins
    Female
    Diabetes mellitus
    type 2
    Cardiovascular events
    Cardiovascular diseases
    Biomarkers
    Biomarker
    Aged
    Cardiac & Cardiovascular Systems
    Cardiology and Cardiovascular Medicine
    Endocrinology & Metabolism
    Endocrinology
    Diabetes and Metabolism
    Internal Medicine
    Saúde coletiva
    Medicina ii
    Medicina i
    Interdisciplinar
    Farmacia
    Educação física
    Ciências biológicas ii
    Ciências biológicas i
    Biotecnología
  • Documents:

  • Cerca a google

    Search to google scholar